triamterene has been researched along with Acquired Autoimmune Hemolytic Anemia in 3 studies
Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Habibi, B | 1 |
Sollet, JP | 1 |
Bleichner, G | 1 |
Takahashi, H | 2 |
Tsukada, T | 2 |
3 other studies available for triamterene and Acquired Autoimmune Hemolytic Anemia
Article | Year |
---|---|
[Treatment with triamterene. Immunologic hemolytic anemia and acute renal insufficiency].
Topics: Acute Kidney Injury; Anemia, Hemolytic, Autoimmune; Humans; Male; Middle Aged; Triamterene | 1983 |
Triamterene-induced immune haemolytic anaemia with acute intravascular haemolysis and acute renal failure.
Topics: Acute Kidney Injury; Anemia, Hemolytic, Autoimmune; Chemical Phenomena; Chemistry; Complement System | 1979 |
[Triamterene-induced immune hemolytic anemia with acute intravascular hemolysis and acute renal failure (author's transl)].
Topics: Acute Disease; Acute Kidney Injury; Anemia, Hemolytic, Autoimmune; Female; Hemolysis; Humans; Middle | 1979 |